Table 4.
Total Sample | No Depressive/Anxiety Disorders | Any DSM-IV Anxiety or Depressive Disorder | Test Statistics t(765) or X2(1) |
---|---|---|---|
Demographics N (%) | 643 (83%) | 125 (17%) | |
Age (Mean ± SD) | 13.9 ± 1.9 | 14.2 ± 2.0 | 1.17 |
N (%) Female | 276 (43.0) | 80 (64.0) | 17.73*** |
Education Level of Most Educated Parent:
N (%) High School Graduate or Less N (%) Some College N (%) College Graduate or More |
43 (6.8) 269 (42.4) 323 (50.9) |
18 (15.4) 57 (46.9) 47 (37.7) |
11.73** df = 2 |
Parent Ethnicity (N = 765)
Caucasian N (%) African-American N (%) Asian & Pacific Islander N (%) Native American N (%) Other N (%) |
514 (81.4) 33 (5.2) 23 (3.6) 42 (6.6) 20 (3.2) |
91 (74.6) 15 (12.3) 3 (2.5) 9 (7.4) 4 (3.2) |
9.16 df = 5 |
N (%) Any Parent Employed PT or FT (N = 756) | 598 (94.3) | 110 (90.2) | 2.32 |
Parental Marital Status (N = 756)
N (%) Married N (%) Single N (%) Divorced, Separated, Widowed |
481 (75.9) 40 (6.9) 113 (17.8) |
70 (57.4) 15 (12.3) 37 (30.3) |
17.90*** df = 2 |
N (%) Eastern WA | 218 (34.0) | 42 (33.6) | 0.00 |
N (%) Medicaid | 79 (12.3) | 25 (20.2) | 4.82* |
Median Household Income in 1999 ($) | 51091 ± 16806 | 47212 ±17841 | 2.19* |
Clinical | |||
Years Since Asthma Diagnosis | 7.4 ± 4.3 | 6.4 ± 4.3 | 2.27* |
Medical Comorbidity Score (PedCDS without asthma) | 580.5 ± 962.5 | 794.8 ± 934.5 | 2.28* |
N (%) Smoking At Least 100 Cigs in Life | 23 (3.6) | 14 (11.3) | 11.83*** |
CBCL Externalizing | 8.6 ± 7.9 | 12.5 ± 9.4 | 4.30*** |
Asthma Severity | |||
N (%) Severe on the Asthma Severity Measure: Any one of the following:
● ER or inpatient asthma visit ● ≥1 oral steroid prescription ● ≥4 outpatient visits |
190 (29.5) |
43 (34.4) |
0.95 |
N (%) Severe on the HEDIS Asthma Severity Measure: Any one of the following:
● ER or inpatient asthma visit ● ≥4 outpatient visits ● ≥4 asthma prescriptions of any kind |
447 (69.6) |
86 (68.8) |
0.01 |
Symptom Days in Last 2 Weeks | 3.5 ± 3.9 | 5.4 ± 4.2 | 4.53*** |
Physical Health (CHS-A) Subscale | 75.9 ± 14.4 | 62.4 ± 16.4 | 9.32*** |
Activity Limitations Scale (CHS-A) Subscale | 85.6 ± 16.2 | 74.2 ± 18.1 | 6.52*** |
N (%) Controller Medication Prescribed (leukotrine inhibitor, inhaler-steroid, long-acting beta-agonist)
% Any One Medication N (%) inhaled steroid N (%) Leukotriene modifier N (%) long-acting beta-agonist N (%)Two or Three Medications |
475 (73.9) 441 (68.6) 97 (15.1) 114 (17.8) 154 (24.0) |
90 (72.6) 85 (68.5) 16 (12.8) 12 (9.7) 20 (16.0) |
0.04 0.00 0.16 4.37* 3.36 |
p < 0.05;
p < 0.01;
p < 0.001